Event
BMCS Hot Topics: Antibody – Drug Conjugates
Date
Thursday 20th November 2025 (afternoon) 13:00 – 17:00 UK Time
Place
Online event, Zoom
Important links and downloads
X Hashtag – #HotTopicsADCs
Synopsis
The BMCS Hot Topics online meetings are intended to highlight breaking areas of research in fields of science relevant to drug discovery. They will run as stand-alone half-day virtual events, 2-3 times per year. The programme will be targeted towards researchers working who would like to enhance their understanding of these nascent or developing fields.
Antibody-drug conjugates (ADCs), alongside other targeted modalities, effectively enrich target tissues with potent payloads unsuitable for systemic administration. With several recent clinical successes, the number of new ADCs approaching the clinic is rapidly increasing. This meeting aims to highlight the technological advancements and innovations driving these ADCs, while addressing the challenges and opportunities within the field. The Hot Topics session will feature speakers from industry and academia who are at the forefront of ADC design.
Registration fees:
RSC Member – £55.00
Non-Member – £75.00
RSC Student Member – £40.00
Student Non-Member – £50.00
Organising Committee
Sharan Bagal, AstraZeneca
Daniel O Donovan, AstraZeneca
Helen Aylott, Redx Pharma
Maximillian Lee, AstraZeneca
Charlotte Hardy, Charles River
Karina Chan, GSK
Hannah Fowler, RSC
BMCS Hot Topics: Antibody – Drug Conjugates
Date
Thursday 20th November 2025 (afternoon) 13:00 – 17:00 UK Time
Place
Online event, Zoom
Important links and downloads
X Hashtag – #HotTopicsADCs
Synopsis
The BMCS Hot Topics online meetings are intended to highlight breaking areas of research in fields of science relevant to drug discovery. They will run as stand-alone half-day virtual events, 2-3 times per year. The programme will be targeted towards researchers working who would like to enhance their understanding of these nascent or developing fields.
Antibody-drug conjugates (ADCs), alongside other targeted modalities, effectively enrich target tissues with potent payloads unsuitable for systemic administration. With several recent clinical successes, the number of new ADCs approaching the clinic is rapidly increasing. This meeting aims to highlight the technological advancements and innovations driving these ADCs, while addressing the challenges and opportunities within the field. The Hot Topics session will feature speakers from industry and academia who are at the forefront of ADC design.
Registration fees:
RSC Member – £55.00
Non-Member – £75.00
RSC Student Member – £40.00
Student Non-Member – £50.00
Organising Committee
Sharan Bagal, AstraZeneca
Daniel O Donovan, AstraZeneca
Helen Aylott, Redx Pharma
Maximillian Lee, AstraZeneca
Charlotte Hardy, Charles River
Karina Chan, GSK
Hannah Fowler, RSC
